| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.871273 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240220151437 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 190408t20182018onca ob f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 041 | |aeng|bfre |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aD68-2/189-2018E-PDF |
|---|
| 100 | 1 |aStratilo, Chad W., |eauthor. |
|---|
| 245 | 10|aIdentification of a novel virulence factor of Burkholderia pseudomallei and B. mallei, a protective vaccine antigen against melioidosis / |cChad W. Stratilo, Rick Swayze, Scott Jager, DRDC - Suffield Research Centre. |
|---|
| 264 | 1|aMedicine Hat, Alberta : |bDefence Research and Development Canada = Recherche et développement pour la défense Canada, |c2018. |
|---|
| 264 | 4|c©2018 |
|---|
| 300 | |a1 online resource (vi, 19 pages, 2 unnumbered pages) : |billustrations. |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 490 | 1 |aScientific report ; |vDRDC-RDDC-2018-R189 |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Can unclassified." |
|---|
| 500 | |a"October 2018." |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | 3 |a"Burkholderia pseudomallei is the causative agent of melioidosis, a severe systemic, potentially life-threatening disease with many possible manifestations in humans. This pathogen expresses a large number of virulence factors, with many found on islands of pathogenesis. Significant efforts have been invested into vaccine development; however none have offered complete protection. A unique and conserved protein of B. pseudomallei and B. mallei has been identified as the exoprotein of a two-partner secretion pathway. This exoprotein, when expressed in a recombinant form effected the formation of actin tails in macrophage cell culture, suggesting a role in intracellular spread and a possible role in virulence. A truncated recombinant form of this protein conferred protection against B. pseudomallei and B. mallei challenge in mice when used as a vaccine candidate"--Abstract, page i. |
|---|
| 546 | |aIncludes abstract in French. |
|---|
| 653 | 10|aBurkholderia pseudomallei |
|---|
| 653 | 10|aBurkholderia mallei |
|---|
| 653 | 10|aMelioidosis |
|---|
| 653 | 10|aRecombinant proteins |
|---|
| 692 | 07|2gccst|aImmunization |
|---|
| 700 | 1 |aSwayze, Rick, |eauthor. |
|---|
| 700 | 1 |aJager, Scott, |eauthor. |
|---|
| 710 | 1 |aDefence R&D Canada - Suffield. |
|---|
| 830 | #0|aScientific report (Defence R&D Canada)|vDRDC-RDDC-2018-R189.|w(CaOODSP)9.802305 |
|---|
| 856 | 40|qPDF|s728 KB|uhttps://publications.gc.ca/collections/collection_2019/rddc-drdc/D68-2-189-2018-eng.pdf |
|---|